The impact of complement activation on tumor oxygenation during photodynamic therapy

Photochemistry and Photobiology

Volumn 83, Issue 5, 2007, Pages 1049-1055

  Cecic, Ivana ^a   Minchinton, Andrew I ^a   Korbelik, Mladen ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ANIMAL; C57BL MOUSE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; EXPERIMENTAL NEOPLASM; METABOLISM; MOUSE; MOUSE MUTANT; PHOTOCHEMOTHERAPY;

ANIMALS; COMPLEMENT ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; OXYGEN; PHOTOCHEMOTHERAPY;

MUS;

EID: 34548754527     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2007.00161.x     Document Type: Conference Paper

References (43)

1. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889 905.
2. Huang, Z. (2005) A review of progress in clinical photodynamic therapy. Technol. Cancer Res. Treat. 4, 283 294.
3. MacDonald, I. J. T. J. Dougherty (2001) Basic principles of photodynamic therapy. J. Porphyrins Phthalocyanines 5, 105 129.
4. Korbelik, M. I. Cecic (2003) Mechanism of tumor destruction by photodynamic therapy. In Handbook of Photochemistry and Photobiology, Vol. 4 (Edited by H. S. Nalwa pp. 39 77. American Scientific Publishers, Stevenson Ranch, CA.
5. Henderson, B. W. S. O. Gollnick (2003) Mechanistic principles of photodynamic therapy. In Biomedical Photonics Handbook (Edited by T. Vo-Dinh pp. 36·1 36·27. CRC Press, Boca Raton, FL.
6. Korbelik, M. (2006) PDT-associated host response and its role in the therapy outcome. Lasers Surg. Med. 38, 500 508.
7. Castano, A. P., P. Mroz M. R. Hamblin (2006) Photodynamic therapy and anti-tumor immunity. Nat. Rev. Cancer 6, 535 545.
8. Cooper, N. R. (1999) Biology of the complement system. In Inflammation: Basic Principles and Clinical Correlations (Edited by J. I. Galin R. Snyderman pp. 281 315. Lippincott Williams & Wilkins, Philadelphia.
9. Sim, R. B. S. A. Tsiftsoglou (2004) Proteases of the complement system. Biochem. Soc. Trans. 32, 21 27.
10. Cecic, I. M. Korbelik (2006) Deposition of complement proteins on cells treated by photodynamic therapy in vitro. J. Environ. Pathol. Toxicol. Oncol. 25, 189 203.
11. Cecic, I., K. Serrano, M. Gyongyossy-Issa M. Korbelik (2005) Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy. Cancer Lett. 225, 215 223.
12. Cecic, I., B. Stott, J. Sun M. Korbelik (2006) Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells. Photochem. Photobiol. 82, 558 562.
13. Wessels, M. R., P. Butko, M. Ma, H. B. Warren, A. L. Lage M. C. Carroll (1995) Studies of group B Streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl Acad. Sci. USA 92, 11490 11494.
14. Korbelik, M. G. Krosl (1996) Photofrin accumulation in malignant and host cell populations of various tumours. Br. J. Cancer 73, 506 513.
15. Krosl, G. M. Korbelik (1994) Potentiation of photodynamic therapy by immunotherapy: The effect of schizophyllan (SPG). Cancer Lett. 84, 43 49.
16. 2 histograph. Adv. Exp. Med. Biol. 471, 507 513.
17. Stone, H. B., J. M. Brown, T. L. Phillips R. M. Sutherland (1993) Oxygen in human tumors: Correlations between methods of measurement and response to therapy (summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland). Radiat. Res. 136, 422 434.
18. Kallinowski, F., S. Runkel, P. F. Vaupel H. Portmeyer (1989) Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res. 49, 3759 3764.
19. Groebe, K. P. Vaupel (1988) Evaluation of oxygen diffusion distances in human breast cancer xenograft using tumor-specific in vivo data: Role of various mechanisms in the development of tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 15, 691 697.
20. Vogel, C. W., R. Bredehorst, D. C. Fritzinger, T. Grunwald, P. Ziegelmuller M. A. Kock (1996) Structure and function of cobra venom factor, the complement-activating protein in cobra venom. Adv. Exp. Med. Biol. 391, 97 114.
21. Henderson, B. W. V. H. Fingar (1987) Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47, 3110 3114.
22. Schmaltz, C., P. Harrigan Hardenbergh, A. Wells D. E. Fisher (1998) Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell Biol. 18, 2845 2854.
23. Henderson, B. W. T. J. Dougherty (1992) How does photodynamic therapy work? Photochem. Photobiol. 55, 145 157.
24. Richter, A. M., E. Waterfield, A. K. Jain, A. J. Canaan, B. A. Allison J. G. Levy (1993) Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem. Photobiol. 57, 1000 1006.
25. Ris, H.-B., H. J. Altermatt, C. M. Stewart, T. Schaffner, Q. Wang, C. K. Lim, R. Bonnett U. Althaus (1993) Photodynamic therapy with m- tetrahydroxyphenylchlorin in vivo: Optimization of the therapeutic index. Int. J. Cancer 55, 245 249.
26. Stott, B. M. Korbelik (2007) Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy. Cancer Immunol. Immunother. 56, 649 658.
27. Bellnier, D. A., Y.-K. Ho, R. K. Pandey, J. R. Missert T. J. Dougherty (1989) Distribution and elimination of Photofrin II in mice. Photochem. Photobiol. 50, 221 228.
28. Bellnier, D. A. T. J. Dougherty (1996) A preliminary pharmacokinetic study of intravenous Photofrin in patients. Clin. Laser Med. Surg. 14, 311 314.
29. 3H-BPD-MA), a new photosensitizer, in normal and tumor-bearing mice. J. Photochem. Photobiol. B Biol. 5, 231 244.
30. Korbelik, M. G. Krosl (1994) Cellular levels of photosensitizers in tumors: The role of proximity to the blood supply. Br. J. Cancer 70, 604 610.
31. Henderson, B. W., T. M. Bush, L. A. Vaughan, N. P. Frawley, D. Babich, T. A. Sosa, J. D. Zollo, A. S. Dee, M. T. Cooper, D. A. Bellnier, W. R. Greco A. R. Oseroff (2000) Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res. 60, 525 529.
32. Fingar, V. H., K. A. Siegel, T. J. Wieman K. W. Doak (1993) The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy. Photochem. Photobiol. 58, 393 399.
33. Hartung, H. P., D. Bitter-Suermann U. Hadding (1983) Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77. J. Immunol. 130, 1345 1349.
34. Fortin, J.-P., J. Bouthillier, S. A. St-Pierre F. Marceau (2002) Contractile effect of anaphylatoxin C5a and of a mimetic peptide on the human umbilical artery: Further evidence for leukocyte-dependent vasomotion. J. Cardiovasc. Pharmacol. 40, 815 821.
35. Samsonov, M., E. Nassonov, V. Masenko, V. Naumov, V. Mareev Y. Belenkov (1993) Anaphylatoxins in dilated cardiomyopathy. J. Intern. Med. 234, 139 142.
36. Cecic, I. M. Korbelik (2002) Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumor. Cancer Lett. 183, 43 51.
37. Fingar, V. H., P. K. Kik, P. S. Haydon, P. B. Cerrito, M. Tseng, E. Abang T. J. Wieman (1999) Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br. J. Cancer 79, 1702 1708.
38. 2 changes during photodynamic therapy depend upon photosensitizer type and time after injection. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 132, 177 184.
39. Moan, J., K. Berg, E. Kvam, A. Western, Z. Malik, A. Ruck H. Schneckenburger (1989) Intracellular localization of photosensitizers. In Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use (Edited by G. Bock S. Harnett pp. 95 107. Wiley, Chichester, UK (Ciba Foundation Symposium 146).
40. Savellano, M. D. T. Hasan (2005) Photochemical targeting of epidermal growth factor receptor: A mechanistic study. Clin. Cancer Res. 11, 1658 1668.
41. Korbelik, M., J. Sun, I. Cecic K. Serrano (2004) Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochem. Photobiol. Sci. 3, 812 816.
42. Korbelik, M. P. D. Cooper (2007) Potentiation of photodynamic therapy of cancer by complement: The effect of γ-inulin. Br. J. Cancer 96, 67 72.
43. Korbelik, M. J. Sun (2006) Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol. Immunother. 55, 900 909.